Current Newsletter

Editorial

20th Edition 

Welcome to GPED's 20th Newsletter!

 

This issue brings exciting news from GPED including valuable opportunities to participate and provide your input!

 

We invite you to attend the upcoming GPED annual general meeting to learn more about our organization and see how YOU can participate. At the ESPE conference in September, there will be a GPED symposium regarding the inclusion of long acting insulin analogues on the WHO list of essential medicines. We invite you to participate by sending your questions and watching this exciting and important debate. Finally, the WHO is seeking input on their Global Diabetes Compact plan as part of the strategy for the management of non communicable diseases, and the Global Accelerator for Paediatric formulations. As health care providers, we have the opportunity to weigh in on the unique challenges of accessing and prescribing pediatric medications. Please consider taking part in these surveys!

We hope you will enjoy these opportunities to participate in global efforts to improve the lives of children with endocrine conditions and diabetes. We will be highlighting new stories from around the world in our fall 2021 newsletter. Enjoy!

GPED Symposium

Join us for an exciting debate on long-acting insulin on September 26th, 11:45AM-12:45PM (Central European Summer Time - CEST)  

Context:

The inclusion of long-acting analogues in the WHO List of Essential Medicines remains controversial. This heated debate will address the cost benefit of long-acting insulin analogues and whether the inclusion of these medications would improve or worsen access to insulin in low- and middle-income countries.

Use of long-acting insulins in low- and middle-income countries - CON (Dr Sanjay Kalra)

Use of long-acting insulins in low- and middle-income countries - PRO (Dr Suzanne Sap)

Biography:

Dr. Sanjay Kalra is a consultant adult endocrinologist at Bharti Hospital, Karnal, India. He is the immediate Past President of the Endocrine Society of India (ESI) (2020/21).

Dr Suzanne Sap Ngo Um is a pediatric endocrinologist. She teaches at the Faculty of Medicine and of Biomedical Sciences at the University of Yaoundé, Cameroon

Send us your questions at info@globalpedendo.org by September 20th and we will ask the debaters to address them. Answers will be posted in the next quarterly GPED newsletter.

WHO's Global Diabetes Compact Stakeholder Update

An opportunity to have your voice heard! 

 

Please see this request by the WHO for civil society consultation and comment on the Global Diabetes Compact plan and other aspects of the non communicable diseases action plans for 2030 between now and Sept 17th - with live consultation on Sept 3rd!

History:

In 2000, the World Health Assembly adopted resolution on the WHO Global Strategy on Non Communicable Diseases (NCD). In 2013, the World Health Assembly endorsed the "WHO Global Action Plan 2013-2020" for the Prevention and Control of NCDs, which comprises a set of actions which will tackle the growing public-health burden imposed by NCDs.  In 2019, the World Health Assembly extended the period of the action plan to 2030.

The WHO Secretariat is convening a global web-based consultation for Member States, UN organizations, and non-State actors on draft recommendations and diabetes coverage targets.

pic3.png

What you can do:

  1. Go to the Global Diabetes Compact plan (https://www.who.int/initiatives/the-who-global-diabetes-compact)

  2. Submit feedback on the Global Diabetes Compact before September 17th 2021 to hemmingsenb@who.int.

 

All relevant feedback received will be published on the WHO website once the web-based consultation is closed. Feedback needs to be submitted in Arabic, Chinese, English, French, Russian and Spanish, but only in the name of an organisation (i.e. GPED), not as an individual.

 

For more information, see https://www.who.int/teams/noncommunicable-diseases/governance

Global Accelerator for Paediatric formulations (GAP-f)

pic4.png

The International Pediatric Association (IPA) is highlighting a WHO initiative to which you can contribute. If interested, please contribute to the survey by August 31, 2021

The World Health Organization (WHO) is initiating a comprehensive analysis of the most needed medicines for children to inform the review of the Essential Medicines List for children (EMLc). The intent is to reach out to healthcare workers, pharmacists and clinicians involved on a day to day basis, who face challenges from the dearth and complexity of appropriate and missing paediatric formulations.

 

The Global Accelerator for Paediatric formulations (GAP-f) is a network led by the World Health Organization. It is a global collaboration that aims to achieve universal health coverage by providing better medicines to children in need.

 

We need your help as a health care professional prescribing, preparing, or administering medicines to children to understand:

·  Which paediatric formulations do you find most problematic and why?

·  Which medicines are missing or are not accessible for the children you care for and why?

To start the survey click here: https://bit.ly/2SS31Im.

 

The survey should not take more than 15 minutes of your time. You can save your responses and return to complete them at any time until the survey is closed on August 31st, 2021.  

GPED Annual General Meeting

The Annual General Assembly of GPED will take place on Sunday September 26 from 12:45-1:15 PM (CET) during the 2021 virtual ESPE meeting

 

The Annual report and a link to this Zoom meeting will be sent to all GPED members.

 

Join us to hear about GPED’s plans and how you can be involved!

pic5.png

Previous Newsletters